Drug Database
Back to search

Japan· JP-2646718N1045

アムシノニド

A amcinonide product containing アムシノニド, registered in Japan by 帝國製薬, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.

On Japan’s NHI price listATC D07AC11

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedアムシノニドATCD07AC11REGISTER NO.JP-2646718N1045PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about アムシノニドAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Amcinonide is registered in 4 of 19 countries.

Countries holding a registration under ATC D07AC11 (amcinonide), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 2 of them publish a price we can compare per daily dose
Search amcinonide products by name

Amcinonide · ATC D07AC11

4 / 19 countries

  • Belgiumprice
  • Canada
  • Japan
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
アムシノニド
Manufacturer
帝國製薬
Country
Japan (JP)
ATC code
D07AC11
ATC class
Amcinonide
Defined daily dose
1.5 mg, T
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for amcinonide.

Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check amcinonide against other medicinesHow interaction checks work

Amcinonide · interactions on record

55 records

  • 55 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same class

    Other records under D07AC11

    Amcinonide, as other registers publish it.

    All amcinonide products

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/ba0c4b31-e68a-4bc8-9303-6bdace525e72
GET /v1/drugs/ba0c4b31-e68a-4bc8-9303-6bdace525e72?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "spec": "０．１％１ｇ",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2646718N1045",
  "category": "外用薬",
  "price_yen": 23.4,
  "generic_name": "アムシノニド",
  "product_name_jp": null,
  "therapeutic_class": "2646",
  "transitional_expiry": null
}
    API referenceMCP serverPlans

    See everything about amcinonide.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console